MedTrace Logo

The Efficacy of Pedometer-motivated Physical Activity for the Management of Patients With MASLD.

NCT06334666 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2025-05-15

No results posted yet for this study

Summary

The study conducted a health survey among Thai adults in 2022 and found a significant increase in obesity and nonalcoholic fatty liver disease (NAFLD), leading to metabolic-associated steatotic liver disease (MASLD). The prevalence of NAFLD was 19.7%, with higher rates in individuals with metabolic syndrome and diabetes. MASLD is associated with insulin resistance and genetic polymorphisms, particularly the patatin like phospholipase domain containing 3-rs738409 variant. Additionally, physical activity was inversely related to liver disease risk, with higher step counts associated with reduced incidence of NAFLD and liver-related mortality. The study aims to investigate the impact of dietary advice and pedometer use on physical activity levels and health outcomes in MASLD patients over 24 weeks.

Conditions

  • Daily Step Count
  • MASLD
  • BMI
  • Metabolic Syndrome
  • NAFLD
  • Insulin Resistance
  • Genetic Polymorphism
  • Cardiovascular Disease (CVD)

Interventions

OTHER

Encourage using pedometer

MASLD patient used pedometer recording actively with encourage by care provider or investigator

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Division of Gastroenterology, Siriraj Hospital · Siriraj Hospital

  • Phunchai Charatcharoenwitthaya, MD · Siriraj Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-06-01
Completion
2026-06-01

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06334666 on ClinicalTrials.gov